Organisation paid for research Program year 2025 Source: CMS Open Payments

Aspirus Clinics Inc

Neither a doctor nor a teaching hospital

Research payments

$365,327

129 payments

Through program year 2025, Aspirus Clinics Inc is reported as receiving $365,327 in research payments, across 129 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$935	1
2024	Research	$13,310	8
2023	Research	$79,172	22
2022	Research	$43,130	15
2021	Research	$39,623	21
2020	Research	$95,003	36
2019	Research	$94,154	26

Breakdown

Who paid Research payments · program years 2019–2025

Abbott Laboratories $318,526 83 payments
Atricure, Inc. $19,829 29 payments
Bayer HealthCare Pharmaceuticals Inc. $16,591 10 payments
Endologix, Inc. $10,381 7 payments

Studies the money was for Research payments · program years 2019–2025

Aveir Dual-Chamber Leadless i2i IDE Study $82,804 15 payments
Hemodynamic-GUIDEd Management of Heart Failure $57,217 12 payments
Hemodynamic Guided Monitoring in Heart Failure (HF) Trial (GUIDE-HF) $42,824 5 payments
Hemodynamic Guided Monitoring in Heart Failure (HF) Trial $29,581 7 payments
Aveir Leadless Pacemaker Dual Chamber IDE Study $28,000 4 payments
SJM Brady MRI Post Approval Study $22,720 6 payments
BAY59-7939 2.5mg reduction atherothrombotic events vs. ASA $16,591 10 payments
Pivotal Study of A Dual Epicardial & Endocardial Procedure (Deep) Approach for Treatment of Subjects With Persistent Or Long Standing Persistent Atrial Fibrillation With Radiofrequency Ablation $12,021 16 payments
Hemodynamic-GUIDEd Management of Heart Failure $11,280 7 payments
SJM Brady MRI Post Approval Study $11,050 7 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.